#biomarin
Latest news and interesting information about biomarin.
BioMarin stock surges on positive hypochondroplasia trial data
BioMarin stock jumped 4.8% after positive Phase 3 trial results for VOXZOGO in hypochondroplasia, showing significant growth improvements.
Biotech at Inflection Point: JPMorgan Covers 14 Firms | Bond.az
JPMorgan covers 14 biotech firms at inflection point, with ratings and price targets. See which companies are poised for growth and the catalysts ahead.
...

